Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

APAC operators accelerate legacy network shutdowns to unlock next phase of 5G growth, reveals GlobalData

Asia-Pacific’s (APAC) mobile landscape is entering a decisive new phase as operators accelerate the retirement of 2G and 3G networks, freeing spectrum and investment capacity to scale advanced 4G and 5G services. The transition marks more than a technology upgrade; it is reshaping competitive dynamics, enabling AI-driven networks, enterprise innovation, and digital infrastructure that will […]
Read more

APAC deal volume dips 12% during January-May 2026 as VC resilience clashes with M&A retreat, reveals GlobalData

The Asia-Pacific (APAC) deal volume dipped by around 12% year-on-year (YoY) during January-May 2026 as resilient venture capital (VC) activity clashed with a heavy mergers & acquisitions (M&A) retreat. While macro caution dragged M&A and private equity (PE), the surge in VC financing signal underlying appetite for innovation, reveals GlobalData, a leading intelligence and productivity […]
Read more

Influencers foresee Asia’s mining expansion amid rising energy security concerns and critical minerals demand, reveals GlobalData

Asia’s mining sector is gaining traction among influencers on X, with discussions focused on energy security, critical minerals and rising demand from electrification, artificial intelligence (AI), and infrastructure development. Key highlights include Vietnam allowing coal mines to exceed licensed capacity, India pushing domestic coal production and gasification, and China tightening controls on strategic mineral extraction. […]
Read more

Digital sovereignty a national security imperative as geopolitical fragmentation worsens, says GlobalData

As geopolitical tensions mount and AI reshapes the digital landscape, governments worldwide face an urgent new reality: true national sovereignty now depends as much on controlling digital infrastructure as it does on physical borders, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Digital Sovereignty”, reveals that nations risk losing control over […]
Read more

Biotech funding recovery favors late-stage, lower-risk assets, reveals GlobalData

The biopharmaceutical industry has seen a recovery in funding through 2026, following a prolonged downturn that limited access to capital across the sector. This recovery includes investment increasingly concentrated in later-stage, lower risk assets rather than early-stage innovation, according to GlobalData, a leading intelligence and productivity platform. According to GlobalData’s State of the Biopharmaceutical Industry […]
Read more

GLP1-RAs emerge as biopharma’s most influential platform drug class, reveals GlobalData

GLP-1 receptor agonists (GLP-1RAs) have contributed significantly to the therapeutic landscape, evolving from a primarily diabetes treatment into leading weight-loss assets with multi-indication capabilities across global pharmaceutical markets. What changed is not just awareness but the convergence of unmet need, a step change in efficacy, and expanding proof of value, turning GLP-1RAs from a diabetes […]
Read more

Tesla job postings in India signal South Asia hub strategy, says GlobalData

Tesla has bolstered its India footprint with a fifth experience center in Hyderabad, complementing the existing sites in Delhi, Gurugram, Bengaluru, and Mumbai. This expansion, combined with a strategic recruitment drive across roles in sales, supply chain, and security, provides the foundational ecosystem required to scale the company’s electric vehicle and clean energy adoption across […]
Read more

Singapore’s rapid IPA nanosensor highlights market potential in gut biomarker diagnostics, says GlobalData

Singapore’s medtech innovation ecosystem continues to demonstrate its strength with the development of a novel fluorescent nanosensor designed to detect indole-3-propionic acid (IPA), a gut microbiome-derived metabolite increasingly studied as a biomarker of gut-related biology and broader health states. Developed by a research collaboration involving National Institute of Education (NIE) NTU, Singapore-MIT Alliance for Research […]
Read more

Biopharma confidence reaches four-year high as dealmaking and innovation gather pace, finds GlobalData

Confidence in the biopharmaceutical industry has climbed to its highest point since 2022, signaling a sector that is regaining momentum despite persistent regulatory and market pressures. The rebound reflects the impact of strategic restructuring, disciplined capital allocation, and renewed investment in innovation. As dealmaking accelerates and funding sentiment improves, the industry appears increasingly positioned to […]
Read more

AI integration in pharmaceutical processes remains focused on high-impact functions, says GlobalData

Artificial Intelligence (AI) has shifted from an experimental technology to an industry-wide operational tool across the pharmaceutical value chain. Companies are prioritizing AI deployment in high-impact areas such as drug discovery, clinical trials, and medical writing, where returns are most tangible. As confidence in AI’s commercial value strengthens, the technology is reshaping R&D economics, accelerating […]
Read more

US drug approvals surpass 10-year average in 2025, reveals GlobalData

The US FDA approved 131 drugs last year through its New Drug Application (NDA), Biologics License Application (BLA), and biosimilar pathways, leading to a steady 4.8% year-on-year increase in approvals. After an uneven decade in which new drug approvals fluctuated widely, the number approved by US regulators in 2025 exceeded the 10-year average, according to […]
Read more

Penumbra’s THUNDERBOLT approval tests peripheral momentum in high-stakes neurovascular market, says GlobalData

Penumbra has recently received FDA approval and CE mark for its THUNDERBOLT system, the first computer-assisted vacuum therapy (CAVT) for stroke. Having recently reclaimed its US peripheral thrombectomy lead via the Lightning Bolt series, the California-based company faces a distinct challenge translating this momentum into the neurovascular sector, where unique anatomy, higher risks, and stringent […]
Read more

North American brands lead sports sponsorship spending in payments sector in 2025, reveals GlobalData

Payment brands prioritize sports sponsorship spending in North America and Europe, as these regions offer the best mix of scale, visibility, and measurable commercial returns. The most active brands are largely payments infrastructure and retail/business-focused, along with the card networks, which use major leagues and global events to achieve scale and consistent activation across markets, […]
Read more

2026 World Snooker Championship signals new era with tech-driven sponsors and Crucible innovations, reveals GlobalData

The 2026 World Snooker Championship, which took place between 18 April to 4 May, marked a pivotal transition for the sport, combining modern venue enhancements with a major commercial evolution. As ticketing structures innovated at the historic Crucible Theatre, the tournament’s commercial profile successfully transitioned away from gambling toward tech-driven partnerships, reflecting broader, family-friendly marketing […]
Read more
1 2 3 4 5 … 770